Reduced BCHE activity in blood plasma is associated with shorter survival times in pancreatic cancer patients [31], and it has been observed to have low expression levels in colorectal carcinoma [32] while exhibiting high expression in oral cancer [33] and ovarian cancer [34]. Here, BCHE is linked to colorectal carcinoma.